Literature DB >> 27808146

Statins and the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients.

Yi-Wen Huang1,2,3, An-Chih Hsieh1, Sien-Sing Yang1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27808146     DOI： 10.1038/ajg.2016.423

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

1.  Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.

Authors:  Yi-Wen Huang; Chia-Long Lee; Sien-Sing Yang; Szu-Chieh Fu; Yun-Yi Chen; Ting-Chuan Wang; Jui-Ting Hu; Ding-Shinn Chen
Journal:  Am J Gastroenterol       Date:  2016-05-10       Impact factor: 10.864

2.  Statins and the Risk of Cirrhosis in Chronic Hepatitis B Patients.

Authors:  Yu-Wen Hu
Journal:  Am J Gastroenterol       Date:  2016-11       Impact factor: 10.864

3.  Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.

Authors:  Yu-Tse Tsan; Chang-Hsing Lee; Wen-Chao Ho; Meng-Hung Lin; Jung-Der Wang; Pau-Chung Chen
Journal:  J Clin Oncol       Date:  2013-03-18       Impact factor: 44.544
  3 in total
  3 in total

Review 1.  Patients With Chronic Liver Disease/Cirrhosis Should Not Take Statin Medications.

Authors:  Christopher Kasia; Steven J Scaglione
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-04-30

Review 2.  Statins Show Promise Against Progression of Liver Disease.

Authors:  Prashanth Francis; Lisa M Forman
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-12-20

3.  Statin inhibits large hepatitis delta antigen-Smad3 -twist-mediated epithelial-to-mesenchymal transition and hepatitis D virus secretion.

Authors:  Yuh-Jin Liang; Cheng-Pu Sun; Yu-Chen Hsu; Yi-Wen Chen; I-An Wang; Chien-Wei Su; Mi-Hua Tao; Jaw-Ching Wu
Journal:  J Biomed Sci       Date:  2020-05-21       Impact factor: 8.410
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.